The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Sudler & Hennessey acquires Viscira in the US

24 Mar 2016 10:00

RNS Number : 1711T
WPP PLC
24 March 2016
 

 FOR IMMEDIATE RELEASE

24 MARCH 2016

 

WPP PLC ("WPP")

 

Sudler & Hennessey acquires Viscira in the US

 

 

WPP announces that its wholly owned operating company, Sudler & Hennessey, a leading global healthcare communications network, has acquired Viscira, LLC ["Viscira"], a leader in digital marketing in the healthcare category.

 

Viscira's unaudited revenues were US$17 million as of December 31, 2015. Its clients include 17 of the world's top 25 pharmaceutical companies comprising over 135 unique brands. Viscira employs over 100 people and is based in San Francisco, with offices New York and London. It was founded in 2007.

 

Viscira develops interactive, digital marketing programs for clients in the pharmaceutical and life sciences industry, allowing them to connect with their audience in unique, differentiated and immersive ways.

 

This acquisition continues WPP's strategy of investing in important disciplines, such as pharmaceutical and healthcare, and markets, such as United States. Sudler & Hennessey is part of WPP's Branding & Identity, Healthcare and Specialist Communications group (which includes Direct and Digital). Collectively, including associates, the companies in this group generate revenues of around US$6 billion and employ over 80,000 people. In the United States WPP companies (including associates) collectively generate revenues of almost US$7 billion and employ 25,000 people.

 

 

Contact:

Feona McEwan, WPP

+ 44(0) 207 408 2204

Kevin McCormack, WPP

+1 (212) 632 2239

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKQDNCBKKKNB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.